北京天智航医疗科技股份有限公司 2025年度业绩快报

Financial Data Summary - The company reported a total operating revenue of 283.26 million yuan for the year 2025, representing a year-on-year increase of 58.38% [3][4] - The net loss attributable to the parent company was 184.03 million yuan, which is an increase of 51.93% compared to the previous year [3][4] - The net profit attributable to the parent company, excluding non-recurring gains and losses, was a loss of 219.54 million yuan, reflecting a year-on-year increase in losses of 29.33% [3][4] - Total assets at the end of the reporting period were 1,723.40 million yuan, an increase of 1.87% from the beginning of the period [3] - The equity attributable to the parent company decreased by 6.40% to 1,186.69 million yuan compared to the beginning of the period [3] Operational Performance Analysis - The significant increase in operating revenue was primarily due to a recovery in the industry market environment, leading to substantial growth in product sales and technical service income [4] - Operating profit decreased by 61.96% year-on-year, with total profit also decreasing by 61.60%, indicating a worsening financial performance [4] - The increase in net loss was attributed to a significant reduction in investment income, increased share-based payment expenses due to the implementation of a restricted stock incentive plan, and an increase in income tax expenses due to the reversal of previously recognized deferred tax assets [4]